fbpx

GBM Awareness Day is July 17. Join us in raising awareness all month long! Learn more.

MindMatters White Logo

Sign up for our bi-monthly email to get the latest news on treatments, support, and stories from the brain tumor community.

Subscribe to MindMatters

Rock for Research in Recognition of GBM Awareness Day

Join us on Wednesday, July 22 as we rally together for the second annual GBM Awareness Day. On this day, we recognize and honor those impacted by a glioblastoma diagnosis, while elevating support for research and treatment of this unforgiving disease. In 2019, leading cancer and health organizations, including the American Brain Tumor Association, urged Congress to pass a resolution that designated a day in July to heighten awareness and commit support for research. The resolution was passed unanimously, and continues to spotlight this life-threatening condition.  

GBM, or glioblastoma multiforme, is the most common, malignant primary brain tumors. Each year, an estimated 13,000 people are impacted by a GBM diagnosis in which science and medicine have yet to pinpoint a cure. For more information about glioblastoma, download our GBM factsheet.

In recognition of GBM Awareness Day, the ABTA is co-hosting Rock for Research, an online concert streamed through the ABTA Facebook page to raise funds for GBM research on July 22. With performances by tribute band, Animation – a Tribute to Rush, this one-hour concert honors Rush drummer Neil Peart, who fought against and passed away from a GBM in January 2020. All concert donations will fund a $50,000 ABTA Discovery Grant for GBM Research

Support GBM Awareness Day

There are a number of ways you can support GBM Awareness Day with the ABTA:

Give a Monthly Gift

Read how Rush band’s biggest fan is doing just that each month, in honor of the late drummer and lyricist. 


 

Make a Difference TOday

Your generosity fuels progress. The American Brain Tumor Association has already invested over $35 million in life-changing brain tumor research, leading to breakthroughs like the FDA approval of vorasidenib, a groundbreaking treatment for low-grade glioma.

Through our Meet Hope Head On campaign, we’re not just funding critical research—we’re also providing free resources and support to patients and caregivers navigating the challenges of a brain tumor diagnosis.

Share This Content:

Share:

More Posts

Upcoming Events

Educational Resources

Always free for patients & caregivers

Gina & Tim Abbas
Caregiver & Anaplastic Astrocytoma Survivor

Double Your Impact for Brain Tumor Families

Donate now and your gift will be matched thanks to the Will Hicks Charitable Association.